Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2006 2
2009 1
2011 1
2012 3
2013 4
2014 4
2015 1
2016 1
2017 2
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, Lammers JJ, Weenink C, Yousaf-Khan U, Horeweg N, van 't Westeinde S, Prokop M, Mali WP, Mohamed Hoesein FAA, van Ooijen PMA, Aerts JGJV, den Bakker MA, Thunnissen E, Verschakelen J, Vliegenthart R, Walter JE, Ten Haaf K, Groen HJM, Oudkerk M. de Koning HJ, et al. Among authors: weenink c. N Engl J Med. 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793. Epub 2020 Jan 29. N Engl J Med. 2020. PMID: 31995683 Clinical Trial.
Quantification of growth patterns of screen-detected lung cancers: The NELSON study.
Heuvelmans MA, Vliegenthart R, de Koning HJ, Groen HJM, van Putten MJAM, Yousaf-Khan U, Weenink C, Nackaerts K, de Jong PA, Oudkerk M. Heuvelmans MA, et al. Among authors: weenink c. Lung Cancer. 2017 Jun;108:48-54. doi: 10.1016/j.lungcan.2017.02.021. Epub 2017 Mar 1. Lung Cancer. 2017. PMID: 28625647 Free article.
Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
Yousaf-Khan U, van der Aalst C, de Jong PA, Heuvelmans M, Scholten E, Lammers JW, van Ooijen P, Nackaerts K, Weenink C, Groen H, Vliegenthart R, Ten Haaf K, Oudkerk M, de Koning H. Yousaf-Khan U, et al. Among authors: weenink c. Thorax. 2017 Jan;72(1):48-56. doi: 10.1136/thoraxjnl-2016-208655. Epub 2016 Jun 30. Thorax. 2017. PMID: 27364640 Clinical Trial.
Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules?
Scholten ET, de Jong PA, de Hoop B, van Klaveren R, van Amelsvoort-van de Vorst S, Oudkerk M, Vliegenthart R, de Koning HJ, van der Aalst CM, Vernhout RM, Groen HJ, Lammers JW, van Ginneken B, Jacobs C, Mali WP, Horeweg N, Weenink C, Thunnissen E, Prokop M, Gietema HA. Scholten ET, et al. Among authors: weenink c. Eur Respir J. 2015 Mar;45(3):765-73. doi: 10.1183/09031936.00005914. Epub 2014 Nov 27. Eur Respir J. 2015. PMID: 25431271 Free article. Clinical Trial.
Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
Horeweg N, van Rosmalen J, Heuvelmans MA, van der Aalst CM, Vliegenthart R, Scholten ET, ten Haaf K, Nackaerts K, Lammers JW, Weenink C, Groen HJ, van Ooijen P, de Jong PA, de Bock GH, Mali W, de Koning HJ, Oudkerk M. Horeweg N, et al. Among authors: weenink c. Lancet Oncol. 2014 Nov;15(12):1332-41. doi: 10.1016/S1470-2045(14)70389-4. Epub 2014 Oct 1. Lancet Oncol. 2014. PMID: 25282285 Clinical Trial.
Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Horeweg N, Scholten ET, de Jong PA, van der Aalst CM, Weenink C, Lammers JW, Nackaerts K, Vliegenthart R, ten Haaf K, Yousaf-Khan UA, Heuvelmans MA, Thunnissen E, Oudkerk M, Mali W, de Koning HJ. Horeweg N, et al. Among authors: weenink c. Lancet Oncol. 2014 Nov;15(12):1342-50. doi: 10.1016/S1470-2045(14)70387-0. Epub 2014 Oct 1. Lancet Oncol. 2014. PMID: 25282284 Clinical Trial.
Reversal of vascular leak with imatinib.
Aman J, Peters MJ, Weenink C, van Nieuw Amerongen GP, Vonk Noordegraaf A. Aman J, et al. Among authors: weenink c. Am J Respir Crit Care Med. 2013 Nov 1;188(9):1171-3. doi: 10.1164/rccm.201301-0136LE. Am J Respir Crit Care Med. 2013. PMID: 24180451 No abstract available.
European randomized lung cancer screening trials: Post NLST.
Field JK, van Klaveren R, Pedersen JH, Pastorino U, Paci E, Becker N, Infante M, Oudkerk M, de Koning HJ; European Randomized Screening Trial Group. Field JK, et al. J Surg Oncol. 2013 Oct;108(5):280-6. doi: 10.1002/jso.23383. Epub 2013 Jul 25. J Surg Oncol. 2013. PMID: 23893464
Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial.
Horeweg N, van der Aalst CM, Vliegenthart R, Zhao Y, Xie X, Scholten ET, Mali W, Thunnissen E, Weenink C, Groen HJ, Lammers JW, Nackaerts K, van Rosmalen J, Oudkerk M, de Koning HJ. Horeweg N, et al. Among authors: weenink c. Eur Respir J. 2013 Dec;42(6):1659-67. doi: 10.1183/09031936.00197712. Epub 2013 Jul 11. Eur Respir J. 2013. PMID: 23845716 Free article. Clinical Trial.
19 results